Business Group on Health: U.S. pharmaceutical supply chain needs overhaulThe Pharmaceutical Supply Chain Leadership Forum has made 70 specific reform recommendations, many of which address the need for increased transparency in therapeutic alternatives and actual out-of-pocket costs. FDA tentatively OKs Zydus Cadila’s generic ImbruvicaZydus Cadila's generic Imbruvica tablets provide a treatment for certain types of cancer. Roundup: Recent generic launches Taking a look at some of the innovative new generics making their debut: Hy-Vee to host COVID-19 vaccination clinics during Iowa State Fair Individuals can receive a $10 Hy-Vee gift card for completing a COVID-19 vaccine. Optum Frontier Therapies debuts in Las Vegas Optum Frontier Therapies' flagship location will serve rare disease patients in all 50 states. Beximco receives FDA nod for Baclofen Baclofen had a market value of more than $110 million in 2020, according to IQVIA. Seqirus starts shipping influenza vaccines for 2021/22 flu season Rolling with the punches: Generics firms innovate, expand scope to stay competitive As they continue to navigate pandemic headwinds, generics firms look to broaden their portfolios and vertically integrate to keep competitive. GSK starts shipping influenza vaccines for 2021-2022 season GSK said it expects to distribute a record supply of more than 50 million doses of its influenza vaccine for the upcoming flu season. FDA approves new Shingrix indication Shingrix is now approved for the prevention of shingles in those who are immunocompromised. First Previous 269 270 271 272 273 Next Last